Received this as an emailZoono Group Limited (ASX:ZNO) | ASX...

Received this as an email

Zoono Group Limited (ASX:ZNO) | ASX Announcement   Zoono Group Releases New Videos | Products, Investment, Industry     Zoono Group Limited (ASX:ZNO) is pleased to release new videos featuring our Founder and CEO Paul Hyslop. Paul introduces our global biotech company and explains how we develop, manufacture and distribute a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions.   Watch Paul’s introduction to Zoono Group  Paul also showcases how to use our products and explains how our technology is based on the ‘Zoono Molecule’ - a unique antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould.    Watch Paul showcase our products & technology   Zoono Group is committed to building an industry leadership position and Paul outlines how we’ve established a global network of customers and distributors spread across many countries and territories.   Watch Paul outline our global expansion   Zoono Group is founded on technology focussed on long lasting antimicrobial protection products. As an industry expert Paul tells The Capital Network’s Lelde Smits why this emerging industry is set for compelling developments.   Watch Paul detail the global investment opportunity   Subscribe to our YouTube page for recent developments   Corporate Enquiry Paul Hyslop CEO/Managing Director P: + 64 2165 9977 E: [email protected] Media Enquiry Julia Maguire The Capital Network P: +61 419 815 386 E: [email protected]     Zoono is a global biotech company that develops, manufactures and distributes a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions.    Zoono produces aerosol-based sprays suited for skin care, surface sanitisers, and treatments for acne and mould remediation. The products are based on the ‘zoono molecule’, a unique antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould.    Zoono’s products have received numerous regulatory approvals and the company’s technology claims are supported by independent testing conducted in laboratories worldwide. Zoono is headquartered in New Zealand and its products are available globally.   To learn more please visit: www.zoono.com